Rapid Micro Biosystems vs Seer
Rapid Micro Biosystems is the larger business, with $33.6m of revenue in fiscal 2025 against $16.6m for Seer (2.0 times as much). Rapid Micro Biosystems grew faster (19.7% against 17.0%). Rapid Micro Biosystems kept more of each dollar of sales as profit: a net margin of -140.3% against -444.0%.
| Latest fiscal year | Rapid Micro BiosystemsRPID, 2025 | SeerSEER, 2025 |
|---|---|---|
| Revenue | $33.6m | $16.6m |
| Revenue growth | 19.7% | 17.0% |
| Net income | −$47.1m | −$73.6m |
| Operating margin | — | -470.5% |
| Net margin | -140.3% | -444.0% |
| Return on equity | -86.8% | -25.1% |
| Free cash flow | −$31.9m | −$46.2m |
| Cash | $20.0m | $47.3m |
| Total debt | $18.9m | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 171 | — |
| Market value | $34.2m | $94.7m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | 22 (Weak) |
| Insider trades, 12 months | 0 buys, 14 sales | 0 buys, 7 sales |